Integration of measurable residual disease by WT1 gene expression and flow cytometry identifies pediatric patients with high risk of relapse in acute myeloid leukemia

We only have this paper's title and publication details.

Observational study demonstrates that combining WT1 gene expression and flow cytometry detects measurable residual disease in pediatric acute myeloid leukemia, highlighting enhanced relapse...